Warren Averett Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History
Warren Averett Asset Management, LLC
- $9.72 Billion
- Q3 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 5,185 shares of BMRN stock, worth $283,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,185Holding current value
$283,775% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
670Shares Held
182MCall Options Held
1.52MPut Options Held
1.01M-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...